MariMed Inc. (OTCMKTS:MRMD – Free Report) – Equities researchers at Ventum Cap Mkts issued their FY2026 earnings estimates for shares of MariMed in a research note issued on Thursday, November 7th. Ventum Cap Mkts analyst A. Semple anticipates that the company will earn $0.00 per share for the year. Ventum Cap Mkts has a “Strong-Buy” rating on the stock.
MariMed Stock Up 10.5 %
OTCMKTS:MRMD opened at $0.16 on Monday. The firm has a market capitalization of $62.19 million, a P/E ratio of -5.45 and a beta of 2.80. MariMed has a 1-year low of $0.14 and a 1-year high of $0.39. The company’s fifty day moving average price is $0.16 and its 200-day moving average price is $0.19. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.55 and a quick ratio of 0.73.
MariMed Company Profile
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.
Recommended Stories
- Five stocks we like better than MariMed
- How to Invest in the FAANG Stocks
- California Resources Stock Could Be a Huge Long-Term Winner
- How to buy stock: A step-by-step guide for beginners
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
